Rizatriptan-induced liver toxicity. Report of a case

Montserrat Gil, Blai Dalmau, Mireia Miquel, Mercedes Vergara, Meritxell Casas, Jordi Sanchez-Delgado, Alberto Fernandez-Atutxa

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

4 Cites (Scopus)

Resum

Triptans are a class of drugs with proven efficacy in the acute treatment of migraine headache. The first component of these drugs was sumatriptan, with various derivatives subsequently emerging. Until now, there has only been one reported case of liver toxicity with zolmitriptan. We now present a case of hepatotoxicity related to another drug in this group: rizatriptan. © 2012 Elsevier España, S.L. and AEEH y AEG.
Idioma originalAnglès
Pàgines (de-a)261-263
RevistaGastroenterologia y Hepatologia
Volum36
Número4
DOIs
Estat de la publicacióPublicada - 1 d’abr. 2013

Fingerprint

Navegar pels temes de recerca de 'Rizatriptan-induced liver toxicity. Report of a case'. Junts formen un fingerprint únic.

Com citar-ho